Search details
1.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36384247
2.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36177902
3.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol
; 40(1): 31-39, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34694649
4.
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study.
Ann Hematol
; 99(2): 283-291, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31872361
5.
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Ann Hematol
; 99(2): 277-282, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31872362
6.
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Am J Hematol
; 95(9): 1030-1037, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32419224
7.
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).
Br J Haematol
; 185(4): 713-717, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30793297
8.
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
Ann Hematol
; 97(9): 1619-1626, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29663029
9.
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study.
Br J Haematol
; 178(4): 588-591, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28485042
10.
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.
Blood
; 126(8): 950-6, 2015 Aug 20.
Article
in English
| MEDLINE | ID: mdl-26089397
11.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28775121
12.
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Ann Hematol
; 100(1): 303-304, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33219839
13.
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Br J Haematol
; 169(4): 544-51, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25817296
14.
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization.
Hematol Oncol
; 33(3): 125-32, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-24890497
15.
Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
Lancet Oncol
; 15(7): 730-7, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24831981
16.
Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.
Br J Haematol
; 164(5): 710-6, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24344981
17.
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.
Blood
; 119(9): 2066-73, 2012 Mar 01.
Article
in English
| MEDLINE | ID: mdl-22234681
18.
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination.
Blood
; 120(16): 3222-8, 2012 Oct 18.
Article
in English
| MEDLINE | ID: mdl-22927246
19.
Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice.
Cancers (Basel)
; 16(10)2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38791909
20.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38181782